Figure 5
From: Non-coding RNAs predict recurrence-free survival of patients with hypoxic tumours
PiSco predicts recurrence-free survival (RFS) of patients with hypoxic tumours. The tumour-type specific score of piRNAs upregulated in hypoxia (PiSco) can classify patients with hypoxic tumours according to the Winter metagene signature into low and high RFS (A) LUSC, (B) HNSC, (C) LUAD). The LUAD PiSco is also a strong predictor of RFS in patients with hypoxic stage I LUAD (D).
